N-(4-METHOXYPHENYL)ETHANETHIOAMIDE, 95.0%, 500mg

2-Amino-4-nitrobenzenemethanol, 98.0%, 250mg

2-(4,4-Difluorocyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

2-Phenyl-cyclopropanecarboxylic acid, 95.0%, 250mg

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 25g

3-AMINOOXETANE-3-CARBONITRILE HCL, 95.0%, 5g

4-N-Boc-aminomethyl-cyclohexnone, 96.0%, 250mg

4-(2-Fluorophenyl)thiazole, 95%, 5g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0,25 mm, 0,10 µm, 1 Pezzo(i)

(5E)-5-benzylidene-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

3-(1H-1,2,4-Triazol-1-yl)piperidine, 95.0%, 250mg

(S)-N-(1-(4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-naphthamide, 98.0%, 1mg

1-Methyl-4-(prop-2-yn-1-yl)piperazine, 98%, 25g